Mafosfamide

DB12083InvestigationalSmall molecule

Mafosfamide has been used in trials studying the treatment of Lymphoma, Leukemia, Meningeal Neoplasm, and Brain and Central Nervous System Tumors.

Chemical structure of Mafosfamide
Mechanism
Curator reviewed
Formula / weight
C9H19Cl2N2O5PS2 · 401.25 g/mol (avg)

Resolves to

Compound
UNII5970HH9923CAS88859-04-5PubChem76968809
Structure
InChIKeyPBUUPFTVAPUWDE-UGZDLDLSSA-NSMILESOS(=O)(=O)CCS[C@H]1CCO[P@@](=O)(N1)N(CCCl)CCCl
Targets
P00352ALDH1A1P30838ALDH3A1

What you can answer from here — as of October 13, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
39Drug interactionsStructured to mechanism, not free text
Sign in
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
7+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Mafosfamide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In